ValiRx Shares Drop as Company Raises £1.16M at Discount
AIM-listed life sciences company ValiRx raised up to £1.155 million through a share issue, leading to an 17% drop in its stock price to match the new issue price of 0.2p per share. The fundraising includes a placing of 500 million shares and additional retail offers.
